Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CRTC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RCC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GUSBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC100996792 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALDOA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERBB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD2BP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRHL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DGUOK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPATA41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFAND5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USPL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUPT20H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC24C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC41A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELMO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLUHP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on